SPTX logo

Seaport Therapeutics, Inc. Common Stock

SPTX
Healthcare|Biotechnology|US
$21.50
+1.11 (+5.44%)
DCF Value
$1.08
Tangible Book / Share
$7.42
Cash / Share
$5.43

Financials

Financial Snapshot

Market Cap
$1.15B
Enterprise Value
$1.09B
Revenue (TTM)
$0.00
Net Income (TTM)
-$138.5M
Cash & Investments
$290.4M
Net Cash
$285.7M
Free Cash Flow (TTM)
-$95.7M
Operating CF (TTM)
-$95.6M
Debt/Equity
0.01

Cash Runway & Burn Rate

Cash on Hand
$290.4M
Quarterly Burn
$23.9M
Monthly Burn
$8.0M
Est. Runway
~12.1 quarters
MetricTrend2025TTM
Cash & Investments
$216.0M$290.4M
Operating Cash Flow
-$77.9M-$95.6M
Free Cash Flow
-$78.3M-$95.7M
Capital Expenditure
-$356.0K-$25.0K
Financing Cash Flow
-$873.0K$239.2M

R&D Spending

R&D (TTM)
$91.9M
R&D Intensity
—
R&D Growth vs Prior
+38.5%
MetricTrend2025TTM
Revenue
$0.00$0.00
R&D Expense
$66.3M$91.9M
SG&A
$21.0M$58.3M

Income Statement

MetricTrend2025TTM
Revenue
$0.00$0.00
Cost of Revenue
$0.00$1.1M
Gross Profit
$0.00-$1.1M
R&D
$66.3M$91.9M
SG&A
$21.0M$58.3M
Operating Income
-$87.3M-$150.9M
Interest Expense
$0.00$0.00
Pretax Income
-$74.1M-$138.7M
Net Income
-$74.9M-$138.5M
EPS (Diluted)
-1.94-2.59
EBITDA
-$85.9M-$149.5M
Shares Out. (M)
38.6553.53

Balance Sheet

MetricTrend2025TTM
Cash & Equivalents
$46.0M$61.6M
Short-Term Investments
$169.9M$228.9M
Total Current Assets
$223.2M$299.1M
Total Assets
$249.0M$417.6M
Total Current Liabilities
$12.8M$17.1M
Long-Term Debt
$0.00$0.00
Total Liabilities
$341.6M$20.2M
Stockholders' Equity
-$92.5M$397.5M
Retained Earnings
-$114.1M-$228.5M

Cash Flow Statement

MetricTrend2025TTM
Operating Cash Flow
-$77.9M-$95.6M
Capital Expenditure
-$356.0K-$25.0K
Free Cash Flow
-$78.3M-$95.7M
Investing Cash Flow
-$184.2M-$127.9M
Financing Cash Flow
-$873.0K$239.2M
Issuance of Stock
$1.0K$240.0M
Repurchase of Stock
$0.00$0.00
Net Debt Issuance
$0.00$0.00
Stock Based Comp.
$6.9M$41.9M
Net Change in Cash
-$263.1M$61.6M

Dilution Tracker

Shares Outstanding
54M
5-Year Share Growth
+0.0%
Stock Issuance (TTM)
$240.0M
MetricTrend2025TTM
Shares Out. (M)
38.6553.53
Change vs Prior %—38.5%
Stock Issuance
$1.0K$240.0M
Stock Repurchase
$0.00$0.00
Stock Based Comp.
$6.9M$41.9M

Margins & Profitability

MetricTrend2025TTM
ROE %
80.9%-59.1%
ROA %
-30.1%-33.2%
ROIC %
-36.7%-37.5%

Valuation

P/E (TTM)At Loss
P/S0.00
P/B2.90
EV/EBITDAAt Loss
EV/Revenue0.00
P/FCFAt Loss

Intrinsic Value Models (per share)

DCF Value
$1.08
Tangible Book / Share
$7.42
Net Current Assets / Share
$5.21
Graham Net-Net
$5.11
Cash / Share
$5.43
MetricTrend2025TTM
P/E Ratio
-10.23-8.30
P/S Ratio
0.000.00
P/B Ratio
-8.292.90
EV/EBITDA
-8.45-7.32
EV/Revenue
0.000.00

Analyst Estimates & Quality

Forward Estimates (consensus)

MetricFY2026FY2027FY2028
Revenue$0.00$0.00$0.00
Net Income-$169.5M-$95.2M-$101.8M
EPS$-4.13$-2.45$-2.49
# Analysts (EPS)566